Scientists do know Buruli ulcer is covered by a bacterium, Mycobacterium ulcerans, found in tropical regions such as West Africa. The possible 70 % of Buruli patients are children below 15 years and over the last decade the number of infections on the rise.
The safety and efficacy of the MitraClip system in the in the EVEREST II randomized clinical trial.. The results of the study will be published in an upcoming issue of the Journal of the American College of Cardiology. The MitraClip system is designed to reduce significant MR by clipping together the leaflets of the mitral valve, one of the four heart valves. The catheter-based MitraClip device to the heart through the femoral vein, delivered a blood vessel in the leg. The heart beats normally during the procedure, and therefore does not require a heart-lung machine. After treatment, the patients are home home within two to three days and were to recover quickly. Continue reading “Scientists do know Buruli ulcer is covered by a bacterium.”